home
portfolio
team
careers
contact
investor portal
home
portfolio
team
careers
contact
investor portal
Nextech Invest
Laronde Attracts $440M in First External Financing to Further Advance Endless RNA™ Platform
Laronde Attracts $440M in First External Financing to Further Advance Endless RNA™ Platform
Post navigation
Previous Post
Previous
Turning Point Therapeutics Announces Early Clinical Data for Repotrectinib in NTRK Fusion-Positive Advanced Solid Tumors Selected for Late-Breaker Plenary Presentation at 2021 AACR-NCI-EORTC Conference
Next Post
Next
Silverback Therapeutics to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference